Heart valve showdown: which replacement lasts longer in seniors?
NCT ID NCT07210541
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at two surgical options for replacing a worn-out aortic heart valve in people aged 60-74. Researchers compared a standard stented biological valve with a donated human valve (allograft) to see which led to better survival and fewer complications. The goal was to find the safest, most effective choice for these patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALLOGRAFT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Why do stem cell transplant patients skip meds? new study investigates
- Custom 3D-printed bone blocks may improve dental implant success
- Blood test may spot hidden heart valve infections
- Dental bone graft showdown: which material keeps your jaw stronger?
- New bone graft aims to ease pain from spine fractures
- Less invasive heart valve replacement may be better for seniors with small valves